Intrathecal Triples

DRUG4 trials

Sponsors

St. Jude Children's Research Hospital

Conditions

Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Myeloid Leukemia (AML)Leukemia, B-CellLeukemia, T-CellLymphoma, Non-Hodgkin'sMyelodysplastic SyndromeMyelodysplastic Syndrome (MDS)

Phase 1

Panobinostat With Fludarabine and Cytarabine for Treatment of Children With Acute Myeloid Leukemia or Myelodysplastic Syndrome

TerminatedNCT02676323

St. Jude Children's Research HospitalAcute Myeloid Leukemia, Myelodysplastic Syndrome

Start: 2016-05-03End: 2018-04-09Updated: 2018-11-14

Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax

Active, not recruitingNCT05192889

St. Jude Children's Research HospitalRefractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia

Start: 2022-08-25End: 2027-02-28Updated: 2025-09-22

Phase 2

Microtransplantation to Treat Refractory or Relapsed Hematologic Malignancies in Younger Patients

TerminatedNCT02433483

St. Jude Children's Research HospitalAcute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS)

Start: 2015-05-22End: 2017-05-08Updated: 2017-11-01

Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma

TerminatedNCT02518750

St. Jude Children's Research HospitalAcute Lymphoblastic Leukemia, Leukemia, B-Cell, Leukemia, T-Cell +1

Start: 2016-11-23End: 2018-03-11Updated: 2019-04-03